These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1331707)

  • 1. Binding of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine to intact platelets and platelet membranes.
    Valone FH
    Methods Enzymol; 1992; 215():224-8. PubMed ID: 1331707
    [No Abstract]   [Full Text] [Related]  

  • 2. Ginkgolides and platelet-activating factor binding sites.
    Hosford DJ; Domingo MT; Chabrier PE; Braquet P
    Methods Enzymol; 1990; 187():433-46. PubMed ID: 2172741
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets.
    Homma H; Tokumura A; Hanahan DJ
    J Biol Chem; 1987 Aug; 262(22):10582-7. PubMed ID: 3038889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes.
    Hwang SB; Lee CS; Cheah MJ; Shen TY
    Biochemistry; 1983 Sep; 22(20):4756-63. PubMed ID: 6313047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes.
    Chau LY; Tsai YM; Cheng JR
    Biochem Biophys Res Commun; 1989 Jun; 161(3):1070-6. PubMed ID: 2545193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent development of platelet-activating factor antagonists.
    Shen TY; Hussaini I; Hwang SB; Chang MN
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():359-62. PubMed ID: 2546389
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets.
    Nishihira J; Ishibashi T; Imai Y; Muramatsu T
    Tohoku J Exp Med; 1985 Oct; 147(2):145-52. PubMed ID: 3001971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and metabolism of platelet-activating factor by human neutrophils.
    O'Flaherty JT; Surles JR; Redman J; Jacobson D; Piantadosi C; Wykle RL
    J Clin Invest; 1986 Aug; 78(2):381-8. PubMed ID: 3016027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of platelet activating factor by isolated membranes from U937 cells.
    Lee JS; Ong R; Yoo TJ; Chiang T
    Cell Immunol; 1990 Feb; 125(2):415-25. PubMed ID: 2153465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
    Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
    Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor binding to human platelet membranes.
    Valone FH; Ruis NM
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of platelet activating factor to albumin.
    Clay KL; Johnson C; Henson P
    Biochim Biophys Acta; 1990 Oct; 1046(3):309-14. PubMed ID: 2171672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine.
    Valone FH
    Immunology; 1984 May; 52(1):169-74. PubMed ID: 6325330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of platelet-activating factor to platelets of Alzheimer's disease and multiinfarct dementia patients.
    Hershkowitz M; Adunsky A
    Neurobiol Aging; 1996; 17(6):865-8. PubMed ID: 9363797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets.
    Kloprogge E; Mommersteeg M; Akkerman JW
    J Biol Chem; 1986 Aug; 261(24):11071-6. PubMed ID: 3015954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition of tritium-labeled platelet-activating factor binding to rabbit platelet membranes by amiloride and amiloride analogs.
    Hwang SB
    Biochem Biophys Res Commun; 1989 Aug; 163(1):165-71. PubMed ID: 2549986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of platelet-activating factor binding sites on uterine membranes from pregnant rabbits.
    Kudolo GB; Harper MJ
    Biol Reprod; 1989 Oct; 41(4):587-603. PubMed ID: 2559778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.